Annals of Oncology

Editorials:

Heinz Ludwig

European Society of Medical Oncology membership survey
Ann Oncol 15: 181-182; doi:10.1093/annonc/mdh077
[Extract] [FREE Full Text] [PDF] [Request Permissions]

S. Monfardini

Evaluation of renal function in elderly cancer patients
Ann Oncol 15: 183-184; doi:10.1093/annonc/mdh078
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Reviews:

R. C. Winterhalder, F. R. Hirsch, G. K. Kotantoulas, W. A. Franklin, and P. A. Bunn, Jr

Chemoprevention of lung cancer—from biology to clinical reality
Ann Oncol 15: 185-196; doi:10.1093/annonc/mdh051
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. Mandic and T. Vujkov

Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future?
Ann Oncol 15: 197-200; doi:10.1093/annonc/mdh043
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Breast cancer:

R. Colomer, A. Llombart-Cussac, A. Lluch, A. Barnadas, B. Ojeda, V. Carañana, Y. Fernández, J. García-Conde, S. Alonso, S. Montero, J. Hornedo, and V. Guillem

Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain
Ann Oncol 15: 201-206; doi:10.1093/annonc/mdh048
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

L. Biganzoli, A. Goldhirsch, C. Straehle, M. Castiglione-Gertsch, P. Therasse, M. Aapro, A. Minisini, and M. J Piccart

Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG)
Ann Oncol 15: 207-210; doi:10.1093/annonc/mdh062
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. Atalay, L. Dirix, L. Biganzoli, L. Beex, M. Nooij, D. Cameron, C. Lohrisch, T. Cufer, J. P. Lobelle, M. R. Mattiaci, M. Piccart, and R. Paridaens

The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, ‘Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients’
Ann Oncol 15: 211-217; doi:10.1093/annonc/mdh064
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gynecologic tumors:

P. Morice, C. Deyrolle, A. Rey, D. Atallah, P. Pautier, S. Camatte, A. Thoury, C. Lhomme, C. Haie-Meder, and D. Castaigne

Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery–radiation therapy
Ann Oncol 15: 218-223; doi:10.1093/annonc/mdh050
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gastrointestinal tumors:

G. P. Stathopoulos, K. Syrigos, A. Polyzos, G. Fountzilas, S. K. Rigatos, N. Ziras, A. Potamiannou, I. Tsiakopoulos, N. Androulakis, G. Aravantinos, A. Athanasiadis, P. Papakotoulas, and V. Georgoulias

Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study
Ann Oncol 15: 224-229; doi:10.1093/annonc/mdh065
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. R. Kroep, H. M. Pinedo, G. Giaccone, A. Van Bochove, G. J. Peters, and C. J. Van Groeningen

Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer
Ann Oncol 15: 230-235; doi:10.1093/annonc/mdh063
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

K. Mimori, Y. Tanaka, K. Yoshinaga, T. Masuda, K. Yamashita, M. Okamoto, H. Inoue, and M. Mori

Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer
Ann Oncol 15: 236-241; doi:10.1093/annonc/mdh056
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. Emterling, Å. Wallin, G. Arbman, and X.-F. Sun

Clinicopathological significance of microsatellite instability and mutated RIZ in colorectal cancer
Ann Oncol 15: 242-246; doi:10.1093/annonc/mdh045
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Lung cancer:

S. Ramalingam, C. P. Belani, R. Day, B. A. Zamboni, S. A. Jacobs, and J. R. Jett

Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancer
Ann Oncol 15: 247-251; doi:10.1093/annonc/mdh061
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

T. Yoshida, S. Tanaka, A. Mogi, Y. Shitara, and H. Kuwano

The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer
Ann Oncol 15: 252-256; doi:10.1093/annonc/mdh073
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. J. Byrne and A. K. Nowak

Modified RECIST criteria for assessment of response in malignant pleural mesothelioma
Ann Oncol 15: 257-260; doi:10.1093/annonc/mdh059
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic malignancies:

A. K. Ng, S. Li, D. Neuberg, B. Silver, J. Weeks, and P. Mauch

Factors influencing treatment recommendations in early-stage Hodgkin’s disease: a survey of physicians
Ann Oncol 15: 261-269; doi:10.1093/annonc/mdh044
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. K. Ng, S. Li, D. Neuberg, B. Silver, M. A. Stevenson, D. C. Fisher, and P. M. Mauch

Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin’s disease
Ann Oncol 15: 270-275; doi:10.1093/annonc/mdh067
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. Sieber, H. Tesch, B. Pfistner, U. Rueffer, U. Paulus, R. Munker, R. Hermann, G. Doelken, P. Koch, J. Oertel, S. Roller, P. Worst, H. Bischof, A. Glunz, R. Greil, K. von Kalle, K. P. Schalk, D. Hasenclever, O. Brosteanu, E. Duehmke, A. Georgii, A. Engert, M. Loeffler, and V. Diehl

Treatment of advanced Hodgkin’s disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin’s Lymphoma Study Group HD6 trial
Ann Oncol 15: 276-282; doi:10.1093/annonc/mdh046
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. Mangel, H. A. Leitch, J. M. Connors, R. Buckstein, K. Imrie, D. Spaner, M. Crump, N. Pennell, A. Boudreau, and N. L. Berinstein

Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis
Ann Oncol 15: 283-290; doi:10.1093/annonc/mdh069
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Miscellaneous tumors:

G. M. Marx, G. M. Blake, E. Galani, C. B. Steer, S. E. Harper, K. L. Adamson, D. L. Bailey, and P. G. Harper

Evaluation of the Cockroft–Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients
Ann Oncol 15: 291-295; doi:10.1093/annonc/mdh079
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

R. Biffi, S. Pozzi, A. Agazzi, U. Pace, A. Floridi, S. Cenciarelli, V. Peveri, A. Cocquio, B. Andreoni, and G. Martinelli

Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients
Ann Oncol 15: 296-300; doi:10.1093/annonc/mdh049
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. Aguilar-Ponce, M. Granados-García, V. Villavicencio, A. Poitevin-Chacón, D. Green, A. Dueñas-González, Á. Herrera-Gómez, K. Luna-Ortiz, A. Alvarado, H. Martínez-Said, C. Castillo-Henkel, B. Segura-Pacheco, and J. De la Garza

Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck
Ann Oncol 15: 301-306; doi:10.1093/annonc/mdh071
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

I. Ray-Coquard, P. Thiesse, D. Ranchère-Vince, F. Chauvin, J.-Y. Bobin, M.-P. Sunyach, J.-P. Carret, B. Mongodin, P. Marec-Bérard, T. Philip, and J.-Y. Blay

Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas
Ann Oncol 15: 307-315; doi:10.1093/annonc/mdh058
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Phase I and pharmacokinetics:

C. Monnerat, R. Henriksson, T. Le Chevalier, S. Novello, P. Berthaud, S. Faivre, and E. Raymond

Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer
Ann Oncol 15: 316-323; doi:10.1093/annonc/mdh052
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. Lomas, W. Liauw, D. Packham, K. Williams, A. Kelleher, J. Zaunders, and R. Ward

Phase I clinical trial of a human idiotypic p53 vaccine in patients with advanced malignancy
Ann Oncol 15: 324-329; doi:10.1093/annonc/mdh053
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

P. Eisenberg, F. R. MacKintosh, P. Ritch, P. A. Cornett, and A. Macciocchi

Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: a dose-ranging clinical study
Ann Oncol 15: 330-337; doi:10.1093/annonc/mdh047
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Epidemiology:

F. Levi, F. Lucchini, J. R. Gonzalez, E. Fernandez, E. Negri, and C. La Vecchia

Monitoring falls in gastric cancer mortality in Europe
Ann Oncol 15: 338-345; doi:10.1093/annonc/mdh057
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

F. Levi, C. Pasche, F. Lucchini, C. Bosetti, and C. La Vecchia

Processed meat and the risk of selected digestive tract and laryngeal neoplasms in Switzerland
Ann Oncol 15: 346-349; doi:10.1093/annonc/mdh060
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

H. M. Verkooijen, G. Fioretta, P. O. Chappuis, G. Vlastos, A. P. Sappino, S. Benhamou, and C. Bouchardy

Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results
Ann Oncol 15: 350-353; doi:10.1093/annonc/mdh072
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

M. Colleoni, N. Rotmensz, G. Martinelli, R. Gelber, A. Coates, and A. Goldhirsch

Lesson learned from high-dose chemotherapy for high-risk breast cancer (What you see is what you mean)
Ann Oncol 15: 355-356; doi:10.1093/annonc/mdh054
[Extract] [FREE Full Text] [PDF] [Request Permissions]

F. Bozzetti

Postoperative chemoradiotherapy after curative gastrectomy for cancer
Ann Oncol 15: 356; doi:10.1093/annonc/mdh055
[Extract] [FREE Full Text] [PDF] [Request Permissions]

E. Sprinz, M. Jeffman, P. Liedke, A. Putten, and G. Schwartsmann

Successful treatment of AIDS-related Castleman’s disease following the administration of highly active antiretroviral therapy (HAART)
Ann Oncol 15: 356-358; doi:10.1093/annonc/mdh066
[Extract] [FREE Full Text] [PDF] [Request Permissions]

B. Arora, L. Kumar, A. Sharma, J. Wadhwa, and V. Kochupillai

Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate
Ann Oncol 15: 358-359; doi:10.1093/annonc/mdh068
[Extract] [FREE Full Text] [PDF] [Request Permissions]

M. Fakih

First-line hepatic infusion of pirarubicin in patients with isolated liver metastases: is it really promising?
Ann Oncol 15: 359; doi:10.1093/annonc/mdh070
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Book reviews:

G. Pentheroudakis and N. Pavlidis

Evidence-based Oncology
Ann Oncol 15: 361; doi:10.1093/annonc/mdh074
[Extract] [FREE Full Text] [PDF] [Request Permissions]

E. Deutsch

Chemoradiation in Cancer Therapy
Ann Oncol 15: 361-362; doi:10.1093/annonc/mdh075
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.